Trials / Completed
CompletedNCT02752295
Intensive Stress Coping Intervention Week - A Secondary Prevention For Real World Affective Disorder Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study intents to determine who will benefit from an intensive brief stress coping intervention week (ISCIW) as secondary prevention for real world affective disorder patients.
Detailed description
Affective disorders are associated with a substantial personal and socio-economic burden. This study evaluates an intensive brief stress-coping intervention week (ISCIW) as feasible follow-up treatment for real world patients who suffer from this highly prevalent and chronic stress-related disorders. Stress-associated blood (Interleukin-6, Homocystein, Myeloperoxidase), saliva cortisol and psychosocial screening parameters will be analyzed to determine who will benefit from the ISCIW. All patients were identified in a preventive medical screening before pre-treatment for at least three month as outpatient and the following inclusion to the follow-up ISCIW-trial at the Health and Prevention Center, Sanatorium Hera, Vienna, Austria. For the three planed groups and interventions see interventions and arms.
Conditions
- Affective Disorders
- Psychological Stress
- Inflammation
- Oxidative Stress
- Anxiety Disorders
- Mood Disorders
- Emotions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | stress-coping week | The multidisciplinary team will offer Mindfulness-Based Stress Reduction (MBSR), group psychotherapy (resilience, Cognitive Behavioral Analysis System of Psychotherapy CBASP, psychodynamic therapy), relaxation training, nutrition course, stress-coping and physical training in a group setting. |
| BEHAVIORAL | additional two days follow-up weekend | A two-days follow-up which recapitulates previous treatment elements. |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2016-07-01
- Completion
- 2016-07-01
- First posted
- 2016-04-26
- Last updated
- 2016-09-16
Source: ClinicalTrials.gov record NCT02752295. Inclusion in this directory is not an endorsement.